Gland Pharma Statistics
Total Valuation
Gland Pharma has a market cap or net worth of INR 323.70 billion. The enterprise value is 297.31 billion.
Market Cap | 323.70B |
Enterprise Value | 297.31B |
Important Dates
The last earnings date was Friday, August 1, 2025.
Earnings Date | Aug 1, 2025 |
Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
Current Share Class | 164.76M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 73.18M |
Valuation Ratios
The trailing PE ratio is 42.03 and the forward PE ratio is 32.04.
PE Ratio | 42.03 |
Forward PE | 32.04 |
PS Ratio | 5.65 |
PB Ratio | 3.54 |
P/TBV Ratio | 3.68 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 38.60 |
EV / Sales | 5.19 |
EV / EBITDA | 21.88 |
EV / EBIT | 30.57 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.23 |
Debt / FCF | n/a |
Interest Coverage | 22.47 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 6.55% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 13.16M |
Profits Per Employee | 1.77M |
Employee Count | 4,286 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Gland Pharma has paid 3.87 billion in taxes.
Income Tax | 3.87B |
Effective Tax Rate | 33.44% |
Stock Price Statistics
The stock price has decreased by -7.68% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -7.68% |
50-Day Moving Average | 1,827.33 |
200-Day Moving Average | 1,667.01 |
Relative Strength Index (RSI) | 53.01 |
Average Volume (20 Days) | 11,781 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gland Pharma had revenue of INR 57.27 billion and earned 7.70 billion in profits. Earnings per share was 46.75.
Revenue | 57.27B |
Gross Profit | 33.08B |
Operating Income | 9.73B |
Pretax Income | 11.57B |
Net Income | 7.70B |
EBITDA | 13.40B |
EBIT | 9.73B |
Earnings Per Share (EPS) | 46.75 |
Balance Sheet
The company has 29.52 billion in cash and 3.14 billion in debt, giving a net cash position of 26.38 billion.
Cash & Cash Equivalents | 29.52B |
Total Debt | 3.14B |
Net Cash | 26.38B |
Net Cash Per Share | n/a |
Equity (Book Value) | 91.51B |
Book Value Per Share | 555.41 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 57.77%, with operating and profit margins of 16.98% and 13.45%.
Gross Margin | 57.77% |
Operating Margin | 16.98% |
Pretax Margin | 20.21% |
Profit Margin | 13.45% |
EBITDA Margin | 23.40% |
EBIT Margin | 16.98% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 0.91%.
Dividend Per Share | 18.00 |
Dividend Yield | 0.91% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | 0.90% |
Earnings Yield | 2.38% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |